Cytrx Corp (NASDAQ:CYTR)

CAPS Rating: 1 out of 5

A biopharmaceutical research and development company engaged in developing human therapeutic products based primarily upon its small molecule molecular chaperone co-induction technology.

CYTR News and Commentary

Caps

How do you think CYTR will perform against the market?

Add Stock to CAPS Watchlist

All Players

199 Outperform
38 Underperform
 

All-Star Players

21 Outperform
25 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top CYTR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

feenix1944 (< 20)
Submitted June 28, 2014

I've been backing the truck up to buy more CYTR on this recent weakness. I've drilled down pretty deep on the recent Stage IIb trial results and am fully convinced CYTR is a double bagger at the very least, and more likely a triple when the final… More

zzlangerhans (99.70)
Submitted December 01, 2016

CytRx is just the latest company trying to pull off the "our trial succeeded after it failed" scenario for a little lift in share price. After being crushed on the failure of their phase III trial of aldoxorubicin for soft tissue sarcoma in July,… More

CYTR VS S&P 500 (SPY)

Fools bullish on CYTR are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about CYTR.

Recs

0
Member Avatar SmartAce (99.97) Submitted: 5/15/2018 3:05:05 PM : Underperform Start Price: $1.33 CYTR Score: +1.70

Mail some pirates a treasure map leading to the exact spot where you need a hole dug for a tree.

Recs

0
Member Avatar john603 (70.23) Submitted: 11/1/2017 6:55:53 PM : Underperform Start Price: $2.08 CYTR Score: +42.26

drug company headed for reverse split.

Recs

0
Member Avatar DigitalDisco (88.21) Submitted: 11/1/2017 11:01:35 AM : Underperform Start Price: $2.04 CYTR Score: +40.80

reverse split

Leaderboard

Find the members with the highest scoring picks in CYTR.

Score Leader

whatsthepoint

whatsthepoint (99.97) Score: +266.31

The Score Leader is the player with the highest score across all their picks in CYTR.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
mansloth 97.70 6/14/2010 Underperform 3Y $34.82 -96.21% +146.25% +242.45 0 Comment
longtermgrowth09 < 20 8/3/2010 Underperform 5Y $40.32 -96.73% +141.95% +238.68 0 Comment
mathan406 61.25 2/8/2008 Underperform 1Y $82.48 -98.40% +111.92% +210.32 0 Comment
trigfish 70.99 8/16/2007 Underperform 3M $123.35 -98.93% +104.94% +203.87 0 Comment
betoo2002 < 20 1/29/2007 Underperform 3M $92.42 -98.57% +103.15% +201.73 0 Comment
tcampbellla 80.13 3/27/2007 Underperform 5Y $173.42 -99.24% +101.44% +200.68 0 Comment
xds68 91.59 2/23/2007 Underperform NS $161.57 -99.18% +98.91% +198.09 0 Comment
ffruga61 56.57 2/22/2007 Underperform 3M $171.95 -99.23% +98.48% +197.71 0 Comment
protozoa1 94.68 2/21/2007 Underperform NS $198.46 -99.33% +98.36% +197.69 0 Comment
jiminica 78.51 2/16/2007 Underperform 1Y $150.23 -99.12% +98.32% +197.45 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackBroadpointAmTech < 20 10/24/2007 Outperform NS $147.65 -90.29% -8.73% -81.56 4/17/2012 @ $14.34 0 Comment
TrackOppenheimer 75.75 10/19/2007 Outperform NS $139.92 -99.06% +86.25% -185.30 0 Comment

Featured Broker Partners